Land: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Paracetamol; BROMPHENIRAMINE MALEATE; Caffeine
Seven Seas Ltd
R06AB; R06AB51
Paracetamol; BROMPHENIRAMINE MALEATE; Caffeine
325 / 30 / 3 milligram(s)
Film-coated tablet
Product not subject to medical prescription
Substituted alkylamines; brompheniramine, combinations
Marketed
2010-11-05
PACKAGE LEAFLET: INFORMATION FOR THE USER Paracetamol 325mg, Caffeine 30mg, Brompheniramine maleate 3mg READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. However, you still need to use Ilvico carefully to get the best results from it. Ilvico Cold and Flu film-coated tablets will be referred to as Ilvico throughout the leaflet • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. • You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET: 1. What Ilvico is and what it is used for 2. What you need to know before you take Ilvico 3. How to take Ilvico 4. Possible side effects 5. How to store Ilvico 6. Contents of the pack and other information 1. WHAT ILVICO IS AND WHAT IT IS USED FOR Ilvico Cold and Flu film-coated tablets contain paracetamol, caffeine and brompheniramine. Ilvico Cold and Flu film-coated tablets are used for the relief of symptoms associated with the common cold, influenza and upper respiratory tract infections. You must talk to a doctor if you do not feel better or if you feel worse. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ILVICO TABLETS DO NOT TAKE ILVICO IF • You are allergic (hypersensitive) to paracetamol, caffeine or brompheniramine, or any of the other ingredients of Ilvico. • You suffer from severe liver diseases (with or without liver insufficiency), viral hepatitis (increases the risk of liver toxicity) • You suffer from peptic ulcers • Your suffer from severe kidney impairment • You suffer from haemophilia (a disorder that affects blood clotting) • You are less than 12 years old • You are pregnant or are breast-feeding • You have tachyarrhythmia (fast heart rate) • You suffer from narrow-angle g Lestu allt skjalið
Health Products Regulatory Authority 17 April 2019 CRN008QXT Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ilvico Cold and Flu film-coated tablets Paracetamol 325 mg Caffeine 30 mg Brompheniramine maleate 3 mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains: Paracetamol 325mg Caffeine 30mg Brompheniramine maleate 3mg For the full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet White, biconvex round, smooth on both sides, film-coated tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the relief of symptoms associated with the common cold, influenza and upper respiratory tract infections. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral use. ADULTS AND CHILDREN OLDER THAN 12 YEARS One or two tablets taken orally with water three times daily and the maximum dose of 6 tablets daily should not be exceeded. Not recommended for children under the age of 12 years. Renal impairment: It is recommended, when giving paracetamol to patients with renal impairment, to reduce the dose and to increase the minimum interval between each administration to at least 6 hours unless directed otherwise by a physician. The table below is provided for guidance only, noting that a 500mg dose cannot be achieved with this product: Adults: Glomerular filtration rate Dose 10-50 ml/min 500mg every 6 hours* <10ml/min 500mg every 8 hours* Hepatic impairment: In patients with hepatic impairment or Gilbert's Syndrome, the dose should be reduced or the dosing interval prolonged. The daily dose should not exceed 2g/day unless directed by a physician. The elderly: Health Products Regulatory Authority 17 April 2019 CRN008QXT Page 2 of 11 Experience has indicated that normal adult dosage is usually appropriate. However in frail, immobile, elderly subjects or in elderly patients with renal or hepatic impairment, a reduction in the amount or frequency of dosing may be appropriate. The maximum daily dose should not exceed 60mg/kg/day (up to a maximum of Lestu allt skjalið